Indefinite Delivery Contract SPE2DP23D0002

Award Date 3/1/23
Last Date to Order 2/29/24
Federal Agency
Medical Supply Chain
Ultimate Awardee
Not listed
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
The Defense Logistics Agency Troop Support Medical awarded a single award indefinite delivery contract to Seqirus USA Inc. for the supply of injectable influenza virus vaccines. The potential value of the contract vehicle is $22.6 million to be delivered between February 2021 through February 2022. Several firm fixed price delivery orders were subsequently issued against this contract for vaccine quantities between $778 to $6.6 million to support the Agency's medical countermeasures programs....
The Defense Logistics Agency Troop Support Medical awarded a single-award Indefinite Delivery Contract to Seqirus USA Inc. with a potential value of $12,954,518.10 to supply influenza virus vaccinations. Under this contract, three firm fixed price delivery orders have been issued to Seqirus USA Inc. totaling $12,710,418.40 to provide influenza virus vaccinations for the 2022-2023 flu season. The delivery orders require vaccinations be delivered to Summit, New Jersey by August 31, 2022. The...
The Defense Logistics Agency Troop Support Medical awarded a single award indefinite delivery contract to Seqirus USA Inc. for the supply of influenza virus vaccinations. Between June 2020 and November 2020, Seqirus was issued multiple firm fixed price delivery orders against the IDV totaling over $66 million to provide influenza virus vaccines from its Summit, New Jersey facility. The vaccinations were to support the Defense Logistics Agency's medical readiness programs and fulfill requirements...
The Defense Logistics Agency Troop Support Medical awarded an Indefinite Delivery Contract to Glaxosmithkline, LLC with a potential value of $50,705,424.00 to supply influenza virus vaccines. Under this contract, three firm fixed price delivery orders were issued for a total of $33,803,616.00 to provide vaccines from Glaxosmithkline's facility in Research Triangle Park, North Carolina. The periods of performance for the delivery orders range from August 31, 2022 through February 24, 2023. The...
The Defense Logistics Agency Troop Support Medical awarded Sanofi Pasteur Inc. an indefinite delivery contract with a potential value of $8,519,232.30 to supply influenza virus vaccinations. Under this contract, three firm fixed price delivery orders have been issued to date for a total of $5,729,208.20. The delivery orders require Sanofi Pasteur to provide vaccinations from its Swiftwater, Pennsylvania facility to the agency between March 2023 and October 2023. The originating...
The Defense Logistics Agency Troop Support Medical awarded a single-award indefinite delivery contract to Sanofi Pasteur Inc. to supply influenza virus vaccinations. Three firm fixed price delivery orders totaling approximately $4.6 million were placed against this vehicle to procure vaccines for 2022-2023 flu seasons. Deliveries will be made from Sanofi Pasteur's Swiftwater, Pennsylvania facility by specified dates ranging from March 2022 to September 2022. No set-aside provisions were applied....
The Defense Logistics Agency Troop Support Medical awarded an indefinite delivery contract to Glaxosmithkline, LLC to supply influenza virus vaccinations. Delivery orders issued against this vehicle total over $44.5 million and require Glaxosmithkline to provide vaccines from its Research Triangle Park, North Carolina facility. Performance periods range from March 2021 to November 2021. No set-asides or subcontractors are specified. This contract aims to ensure U.S. armed forces and DLA...
The Defense Logistics Agency Troop Support Medical awarded Sanofi Pasteur Inc. a single award, indefinite delivery contract with a potential value of $567,566.40 to provide 850,886,1267 units of influenza virus vaccine. A firm fixed price delivery order against this contract specifies performance at Sanofi Pasteur Inc.'s Swiftwater, Pennsylvania facility from February 9, 2022 through May 13, 2022. The originating pre-solicitation sought sources capable of providing 60,000 doses of Southern...
This federal contract IDV award, SPE2DP25D0004, is a single-award Indefinite Delivery Contract valued at $6,857,675.50 and administered by the Defense Logistics Agency (DLA) Troop Support. The contract was awarded to Seqirus USA Inc., a foreign-owned, for-profit manufacturer of influenza vaccines. The contract aims to procure injectable, egg-free influenza vaccines for the 2025-2026 flu season, with an estimated annual quantity of 280,000 doses and a maximum of 150% of the annual estimate. The...
The Defense Logistics Agency Troop Support awarded a single-award indefinite delivery contract to Sanofi Pasteur Inc. for the supply of Southern Hemisphere influenza vaccine. The potential value of the contract is $397,455. No set-aside was used. The contract aims to procure approximately 29,000 doses of a pre-measured 0.5 mL influenza vaccine for intramuscular administration to individuals aged 6 months and older. The vaccine must be FDA-approved and ACIP recommended, using the formula...
  • SPE2DP23D0002
    Indefinite Delivery Contract
  • 7
    Federal Contract Awards

The Defense Logistics Agency Troop Support Medical awarded an indefinite delivery contract to Seqirus USA Inc. to supply influenza virus vaccines. Under this contract vehicle, multiple firm fixed price delivery orders were issued for vaccine doses valued between $13,975 to over $12 million each. Places of performance are Seqirus' Summit, New Jersey facility. Periods of performance span from March 2023 through October 2023.

The original solicitation sought proposals to supply approximately 3.39 million doses of injectable influenza vaccine for the 2023-2024 flu season. Vaccines were required to be FDA-approved for individuals ages 65 and over, ages 18 and older, ages 3 and older, and include a pediatric formulation for ages 6 months to 35 months. Successful offerors must have FDA approval for their vaccine and an ACIP recommendation. Delivery of 40% of doses by August 2023 and additional staggered deliveries through September 2023 were required. The contract was to be an indefinite delivery, indefinite quantity agreement valued between 75-150% of the estimated 3.39 million doses, all to be delivered to the Defense Depot in New Cumberland, Pennsylvania.

Generated 1/4/24, 9:53 PM